<!DOCTYPE html>
<html lang="en"><head>
<script src="pharma-04_files/libs/clipboard/clipboard.min.js"></script>
<script src="pharma-04_files/libs/quarto-html/tabby.min.js"></script>
<script src="pharma-04_files/libs/quarto-html/popper.min.js"></script>
<script src="pharma-04_files/libs/quarto-html/tippy.umd.min.js"></script>
<link href="pharma-04_files/libs/quarto-html/tippy.css" rel="stylesheet">
<link href="pharma-04_files/libs/quarto-html/light-border.css" rel="stylesheet">
<link href="pharma-04_files/libs/quarto-html/quarto-html.min.css" rel="stylesheet" data-mode="light">
<link href="pharma-04_files/libs/quarto-html/quarto-syntax-highlighting-dark.css" rel="stylesheet" id="quarto-text-highlighting-styles"><meta charset="utf-8">
  <meta name="generator" content="quarto-1.5.57">

  <meta name="author" content="Ian McCarthy | Emory University">
  <title>Regulation and Innovation</title>
  <meta name="apple-mobile-web-app-capable" content="yes">
  <meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
  <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=no, minimal-ui">
  <link rel="stylesheet" href="pharma-04_files/libs/revealjs/dist/reset.css">
  <link rel="stylesheet" href="pharma-04_files/libs/revealjs/dist/reveal.css">
  <style>
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    ul.task-list{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      width: 0.8em;
      margin: 0 0.8em 0.2em -1em; /* quarto-specific, see https://github.com/quarto-dev/quarto-cli/issues/4556 */ 
      vertical-align: middle;
    }
  </style>
  <link rel="stylesheet" href="pharma-04_files/libs/revealjs/dist/theme/quarto.css">
  <link href="pharma-04_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.css" rel="stylesheet">
  <link href="pharma-04_files/libs/revealjs/plugin/reveal-menu/menu.css" rel="stylesheet">
  <link href="pharma-04_files/libs/revealjs/plugin/reveal-menu/quarto-menu.css" rel="stylesheet">
  <link href="pharma-04_files/libs/revealjs/plugin/reveal-chalkboard/font-awesome/css/all.css" rel="stylesheet">
  <link href="pharma-04_files/libs/revealjs/plugin/reveal-chalkboard/style.css" rel="stylesheet">
  <link href="pharma-04_files/libs/revealjs/plugin/quarto-support/footer.css" rel="stylesheet">
  <style type="text/css">

  .callout {
    margin-top: 1em;
    margin-bottom: 1em;  
    border-radius: .25rem;
  }

  .callout.callout-style-simple { 
    padding: 0em 0.5em;
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
    display: flex;
  }

  .callout.callout-style-default {
    border-left: solid #acacac .3rem;
    border-right: solid 1px silver;
    border-top: solid 1px silver;
    border-bottom: solid 1px silver;
  }

  .callout .callout-body-container {
    flex-grow: 1;
  }

  .callout.callout-style-simple .callout-body {
    font-size: 1rem;
    font-weight: 400;
  }

  .callout.callout-style-default .callout-body {
    font-size: 0.9rem;
    font-weight: 400;
  }

  .callout.callout-titled.callout-style-simple .callout-body {
    margin-top: 0.2em;
  }

  .callout:not(.callout-titled) .callout-body {
      display: flex;
  }

  .callout:not(.no-icon).callout-titled.callout-style-simple .callout-content {
    padding-left: 1.6em;
  }

  .callout.callout-titled .callout-header {
    padding-top: 0.2em;
    margin-bottom: -0.2em;
  }

  .callout.callout-titled .callout-title  p {
    margin-top: 0.5em;
    margin-bottom: 0.5em;
  }
    
  .callout.callout-titled.callout-style-simple .callout-content  p {
    margin-top: 0;
  }

  .callout.callout-titled.callout-style-default .callout-content  p {
    margin-top: 0.7em;
  }

  .callout.callout-style-simple div.callout-title {
    border-bottom: none;
    font-size: .9rem;
    font-weight: 600;
    opacity: 75%;
  }

  .callout.callout-style-default  div.callout-title {
    border-bottom: none;
    font-weight: 600;
    opacity: 85%;
    font-size: 0.9rem;
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-default div.callout-content {
    padding-left: 0.5em;
    padding-right: 0.5em;
  }

  .callout.callout-style-simple .callout-icon::before {
    height: 1rem;
    width: 1rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 1rem 1rem;
  }

  .callout.callout-style-default .callout-icon::before {
    height: 0.9rem;
    width: 0.9rem;
    display: inline-block;
    content: "";
    background-repeat: no-repeat;
    background-size: 0.9rem 0.9rem;
  }

  .callout-title {
    display: flex
  }
    
  .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  .callout.no-icon::before {
    display: none !important;
  }

  .callout.callout-titled .callout-body > .callout-content > :last-child {
    padding-bottom: 0.5rem;
    margin-bottom: 0;
  }

  .callout.callout-titled .callout-icon::before {
    margin-top: .5rem;
    padding-right: .5rem;
  }

  .callout:not(.callout-titled) .callout-icon::before {
    margin-top: 1rem;
    padding-right: .5rem;
  }

  /* Callout Types */

  div.callout-note {
    border-left-color: #4582ec !important;
  }

  div.callout-note .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-note.callout-style-default .callout-title {
    background-color: #dae6fb
  }

  div.callout-important {
    border-left-color: #d9534f !important;
  }

  div.callout-important .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-important.callout-style-default .callout-title {
    background-color: #f7dddc
  }

  div.callout-warning {
    border-left-color: #f0ad4e !important;
  }

  div.callout-warning .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-warning.callout-style-default .callout-title {
    background-color: #fcefdc
  }

  div.callout-tip {
    border-left-color: #02b875 !important;
  }

  div.callout-tip .callout-icon::before {
    background-image: url('data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAACAAAAAgCAYAAABzenr0AAAAAXNSR0IArs4c6QAAAERlWElmTU0AKgAAAAgAAYdpAAQAAAABAAAAGgAAAAAAA6ABAAMAAAABAAEAAKACAAQAAAABAAAAIKADAAQAAAABAAAAIAAAAACshmLzAAADr0lEQVRYCe1XTWgTQRj9ZjZV8a9SPIkKgj8I1bMHsUWrqYLVg4Ue6v9BwZOxSYsIerFao7UiUryIqJcqgtpimhbBXoSCVxUFe9CTiogUrUp2Pt+3aUI2u5vdNh4dmMzOzHvvezuz8xNFM0mjnbXaNu1MvFWRXkXEyE6aYOYJpdW4IXuA4r0fo8qqSMDBU0v1HJUgVieAXxzCsdE/YJTdFcVIZQNMyhruOMJKXYFoLfIfIvVIMWdsrd+Rpd86ZmyzzjJmLStqRn0v8lzkb4rVIXvnpScOJuAn2ACC65FkPzEdEy4TPWRLJ2h7z4cArXzzaOdKlbOvKKX25Wl00jSnrwVxAg3o4dRxhO13RBSdNvH0xSARv3adTXbBdTf64IWO2vH0LT+cv4GR1DJt+DUItaQogeBX/chhbTBxEiZ6gftlDNXTrvT7co4ub5A6gp9HIcHvzTa46OS5fBeP87Qm0fQkr4FsYgVQ7Qg+ZayaDg9jhg1GkWj8RG6lkeSacrrHgDaxdoBiZPg+NXV/KifMuB6//JmYH4CntVEHy/keA6x4h4CU5oFy8GzrBS18cLJMXcljAKB6INjWsRcuZBWVaS3GDrqB7rdapVIeA+isQ57Eev9eCqzqOa81CY05VLd6SamW2wA2H3SiTbnbSxmzfp7WtKZkqy4mdyAlGx7ennghYf8voqp9cLSgKdqNfa6RdRsAAkPwRuJZNbpByn+RrJi1RXTwdi8RQF6ymDwGMAtZ6TVE+4uoKh+MYkcLsT0Hk8eAienbiGdjJHZTpmNjlbFJNKDVAp2fJlYju6IreQxQ08UJDNYdoLSl6AadO+fFuCQqVMB1NJwPm69T04Wv5WhfcWyfXQB+wXRs1pt+nCknRa0LVzSA/2B+a9+zQJadb7IyyV24YAxKp2Jqs3emZTuNnKxsah+uabKbMk7CbTgJx/zIgQYErIeTKRQ9yD9wxVof5YolPHqaWo7TD6tJlh7jQnK5z2n3+fGdggIOx2kaa2YI9QWarc5Ce1ipNWMKeSG4DysFF52KBmTNMmn5HqCFkwy34rDg05gDwgH3bBi+sgFhN/e8QvRn8kbamCOhgrZ9GJhFDgfcMHzFb6BAtjKpFhzTjwv1KCVuxHvCbsSiEz4CANnj84cwHdFXAbAOJ4LTSAawGWFn5tDhLMYz6nWeU2wJfIhmIJBefcd/A5FWQWGgrWzyORZ3Q6HuV+Jf0Bj+BTX69fm1zWgK7By1YTXchFDORywnfQ7GpzOo6S+qECrsx2ifVQAAAABJRU5ErkJggg==');
  }

  div.callout-tip.callout-style-default .callout-title {
    background-color: #ccf1e3
  }

  div.callout-caution {
    border-left-color: #fd7e14 !important;
  }

  div.callout-caution .callout-icon::before {
    background-image: url('data:image/png;base64,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');
  }

  div.callout-caution.callout-style-default .callout-title {
    background-color: #ffe5d0
  }

  </style>
  <style type="text/css">
    .reveal div.sourceCode {
      margin: 0;
      overflow: auto;
    }
    .reveal div.hanging-indent {
      margin-left: 1em;
      text-indent: -1em;
    }
    .reveal .slide:not(.center) {
      height: 100%;
    }
    .reveal .slide.scrollable {
      overflow-y: auto;
    }
    .reveal .footnotes {
      height: 100%;
      overflow-y: auto;
    }
    .reveal .slide .absolute {
      position: absolute;
      display: block;
    }
    .reveal .footnotes ol {
      counter-reset: ol;
      list-style-type: none; 
      margin-left: 0;
    }
    .reveal .footnotes ol li:before {
      counter-increment: ol;
      content: counter(ol) ". "; 
    }
    .reveal .footnotes ol li > p:first-child {
      display: inline-block;
    }
    .reveal .slide ul,
    .reveal .slide ol {
      margin-bottom: 0.5em;
    }
    .reveal .slide ul li,
    .reveal .slide ol li {
      margin-top: 0.4em;
      margin-bottom: 0.2em;
    }
    .reveal .slide ul[role="tablist"] li {
      margin-bottom: 0;
    }
    .reveal .slide ul li > *:first-child,
    .reveal .slide ol li > *:first-child {
      margin-block-start: 0;
    }
    .reveal .slide ul li > *:last-child,
    .reveal .slide ol li > *:last-child {
      margin-block-end: 0;
    }
    .reveal .slide .columns:nth-child(3) {
      margin-block-start: 0.8em;
    }
    .reveal blockquote {
      box-shadow: none;
    }
    .reveal .tippy-content>* {
      margin-top: 0.2em;
      margin-bottom: 0.7em;
    }
    .reveal .tippy-content>*:last-child {
      margin-bottom: 0.2em;
    }
    .reveal .slide > img.stretch.quarto-figure-center,
    .reveal .slide > img.r-stretch.quarto-figure-center {
      display: block;
      margin-left: auto;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-left,
    .reveal .slide > img.r-stretch.quarto-figure-left  {
      display: block;
      margin-left: 0;
      margin-right: auto; 
    }
    .reveal .slide > img.stretch.quarto-figure-right,
    .reveal .slide > img.r-stretch.quarto-figure-right  {
      display: block;
      margin-left: auto;
      margin-right: 0; 
    }
  </style>
</head>
<body class="quarto-dark">
  <div class="reveal">
    <div class="slides">

<section id="title-slide" class="quarto-title-block center">
  <h1 class="title">Regulation and Innovation</h1>

<div class="quarto-title-authors">
<div class="quarto-title-author">
<div class="quarto-title-author-name">
Ian McCarthy | Emory University 
</div>
</div>
</div>

</section>
<section id="outline-for-today" class="slide level2">
<h2>Outline for today</h2>
<ol type="1">
<li>Innovation and R&amp;D decisions
<ul>
<li>MEI, dynamic efficiency, and what gets researched</li>
</ul></li>
<li>Prices, competition, and high drug spending
<ul>
<li>U.S. vs peers, brand vs generic, limited competition<br>
</li>
</ul></li>
<li>Policy responses and global equity
<ul>
<li>Price regulation, push vs pull incentives, global public good</li>
</ul></li>
</ol>
</section>
<section>
<section id="innovation-and-rd-decisions" class="title-slide slide level1 center">
<h1>Innovation and R&amp;D Decisions</h1>

</section>
<section id="what-is-innovation" class="slide level2">
<h2>What is innovation?</h2>
<p>How would you define “innovation” in pharma?</p>
<div class="fragment">
<ul>
<li>Should not just mean a new drug, but a new drug that is better than existing treatments</li>
<li>Not clear this is always the argument made in the media</li>
</ul>
</div>
</section>
<section id="inducing-innovation" class="slide level2">
<h2>Inducing Innovation</h2>
<ul>
<li>Governments often care not just about using existing technologies efficiently, but about <em>creating</em> new ones</li>
<li>Classic example: British Parliament’s 1714 Longitude Prize, which paid for a method to determine longitude at sea</li>
<li>The prize worked: it induced decades of R&amp;D by clockmakers, eventually yielding highly accurate marine chronometers</li>
<li>Question for today: what “prizes” or incentives are we implicitly setting for pharma R&amp;D?</li>
</ul>
</section>
<section id="what-governs-innovation" class="slide level2">
<h2>What governs innovation?</h2>
<ul>
<li>Strong empirical evidence that firms internalize future profits of a drug when making R&amp;D decisions</li>
<li>Investment decision can be modeled as:
<ol type="1">
<li>Ranking of expected returns to potential new drugs, including costs of manufacturing, packaging, marketing, and distribution. This is the Marginal Efficiency of Investment (MEI)</li>
<li>Comparison of MEI to cost of capital</li>
<li>Investment in the drugs to the point where MEI=cost of capital</li>
</ol></li>
</ul>
</section>
<section id="mei-and-the-cost-of-capital" class="slide level2">
<h2>MEI and the Cost of Capital</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/mei_cost_of_capital.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
<ul>
<li>Downward-sloping MEI: diminishing returns to additional R&amp;D projects</li>
<li>Horizontal line: cost of capital</li>
<li>A leftward shift of MEI (e.g., from lower prices) reduces the profit-maximizing R&amp;D level</li>
</ul>
</section>
<section id="dynamic-efficiency" class="slide level2">
<h2>Dynamic Efficiency</h2>
<ul>
<li>Policies that lower drug prices today reduce current spending but also reduce expected future profits</li>
<li>If firms internalize these future profits, lower prices → lower MEI → less R&amp;D and fewer future drugs</li>
<li>Dynamic efficiency tradeoff:
<ul>
<li>Static gain: lower prices and better access for today’s patients</li>
<li>Dynamic cost: potential reduction in future innovation</li>
</ul></li>
<li>Example: debates around Medicare drug price negotiation and the Inflation Reduction Act can be viewed through this lens</li>
</ul>
</section>
<section id="what-gets-researched-preventives-vs-treatments" class="slide level2">
<h2>What Gets Researched? Preventives vs Treatments</h2>
<ul>
<li>Even holding total market size fixed, incentives can differ sharply between:
<ul>
<li>Preventive products (e.g., vaccines)</li>
<li>Treatments after disease onset</li>
</ul></li>
<li>Kremer &amp; Snyder show that with heterogeneous risk, firms may earn more from treatments than preventives, even when preventives generate more social surplus</li>
<li>Intuition: high-risk patients are easier to identify and treat; low-risk individuals may not buy prevention at a price that fully reflects its social value</li>
</ul>
</section>
<section id="kremersnyder-stylized-example" class="slide level2">
<h2>Kremer–Snyder Stylized Example</h2>
<ul>
<li>Suppose:
<ul>
<li>Some consumers have a high probability of getting the disease; others have low risk</li>
<li>A preventive reduces risk; a treatment cures the disease after it appears</li>
</ul></li>
<li>With the <em>same</em> underlying health risk and willingness-to-pay:
<ul>
<li>Treatment can yield higher firm revenue than prevention because only high-risk consumers are willing to pay high prices for the preventive</li>
</ul></li>
<li>Takeaway: private R&amp;D may tilt toward treatments over preventives, even when prevention is socially preferable</li>
</ul>
</section>
<section id="kremersnyder-visualizing-revenues" class="slide level2">
<h2>Kremer–Snyder: Visualizing Revenues</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/kremer_snyder_grid.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
<ul>
<li>High-risk patients generate relatively high revenue from both prevention and treatment</li>
<li>Low-risk patients are hard to monetize with prevention, even when prevention is socially valuable</li>
<li>Private R&amp;D may tilt toward treatments, even if prevention yields higher social surplus</li>
</ul>
</section>
<section id="stage-of-disease-and-trial-length" class="slide level2">
<h2>Stage of Disease and Trial Length</h2>
<ul>
<li>Firms also choose <em>which stage</em> of disease to target</li>
<li>Shorter clinical trials mean:
<ul>
<li>Faster time to approval</li>
<li>Longer period of effective market exclusivity</li>
</ul></li>
<li>Empirically, cancer R&amp;D is heavily concentrated in late-stage and recurrent disease, with far fewer trials on prevention or very early-stage disease</li>
<li>This suggests underinvestment in long-term, prevention-oriented projects relative to social value</li>
</ul>
</section>
<section id="evidence-cancer-trials-by-stage" class="slide level2">
<h2>Evidence: Cancer Trials by Stage</h2>
<ul>
<li>Data on cancer clinical trials show:
<ul>
<li>Very high numbers of trials for recurrent and metastatic disease</li>
<li>Much smaller numbers for in situ cancers and especially for prevention trials</li>
</ul></li>
<li>Interpretation:
<ul>
<li>Market incentives favor drugs with shorter, cheaper trials and quicker payoffs</li>
<li>Long-horizon prevention may be dynamically underprovided</li>
</ul></li>
</ul>
</section>
<section id="cancer-trials-by-stage-stylized" class="slide level2">
<h2>Cancer Trials by Stage (Stylized)</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/cancer_trials_by_stage.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
<ul>
<li>Trials are heavily concentrated in metastatic and recurrent disease</li>
<li>Far fewer trials focus on prevention or very early-stage disease</li>
<li>Suggests underinvestment in long-horizon, prevention-oriented projects</li>
</ul>
</section></section>
<section>
<section id="prices-competition-and-high-drug-spending" class="title-slide slide level1 center">
<h1>Prices, Competition, and High Drug Spending</h1>

</section>
<section id="paper-discussion-1" class="slide level2">
<h2>Paper Discussion 1</h2>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/27552619/">The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform</a></p>
</section>
<section id="high-spending" class="slide level2">
<h2>1. High Spending</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/pharma-spending-fig1.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
</section>
<section class="slide level2">

<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/pharma-spending-tab1.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
</section>
<section class="slide level2">

<ul>
<li>Higher spending in the U.S. compared to peer countries</li>
<li>Faster spending growth in the U.S. compared to peer countries</li>
</ul>
<div class="fragment">
<p>But…</p>
<ul>
<li>Spending on even very high cost drugs can still be cost-effective</li>
<li>Sovaldi (hepatitis C) found to be cost-effective despite $84,000 per 12-week course</li>
</ul>
</div>
</section>
<section id="research-questions" class="slide level2">
<h2>Research Questions</h2>
<ul>
<li>What factors seem to contribute to pharma price increases?</li>
<li>What policies can help ensure prices match value and that drugs are available in an equitable way?</li>
</ul>
</section>
<section id="brand-name-vs-generic" class="slide level2">
<h2>Brand name vs generic</h2>
<ul>
<li>Annual cost of highly specialized brand name drugs exceeds $250,000 per patient!</li>
<li>High brand-name prices now extend to drugs with some substitutes (not just rare conditions)</li>
<li>Generic drugs generally lower priced, but some examples of high price increases
<ul>
<li>Daraprim, 63-year old treatment for toxoplasmosis, increases 5500% (from $13.50 to $750) in 2015</li>
<li>A few hundred generic drugs experienced price increases of more than 1000% from 2008 to 2015</li>
<li>Why? Monopoly products, despite no patent protection</li>
</ul></li>
</ul>
</section>
<section id="why-such-high-prices" class="slide level2">
<h2>Why such high prices?</h2>
<ul>
<li>Prices set by manufacturers, PBMs, insurers, and pharmacies</li>
<li>Little direct price regulation</li>
<li>Conversely, the UK specifically requires cost-effectiveness thresholds before allowing coverage</li>
</ul>
</section>
<section id="case-study-avastin-and-price-discrimination" class="slide level2">
<h2>Case Study: Avastin and Price Discrimination</h2>
<ul>
<li>Avastin was approved for certain cancers and priced accordingly</li>
<li>Physicians later discovered that very small doses were also effective for treating macular degeneration</li>
<li>At the cancer price, the implied price per eye injection for ophthalmology was extremely high</li>
<li>Regulatory and reimbursement rules limited Genentech’s ability to charge very different prices across indications, creating tensions around off-label use and follow-on products</li>
<li>Example of how indication, dosing, and pricing regulations interact with firms’ incentives</li>
</ul>
</section>
<section id="drug-life-cycle-and-patent-clock" class="slide level2">
<h2>Drug Life Cycle and Patent Clock</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/drug_lifecycle_timeline.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
<ul>
<li>Legal patent term starts before approval; effective market exclusivity is shorter</li>
<li>Shorter clinical trials bring approval earlier and lengthen effective exclusivity</li>
<li>R&amp;D incentives are shaped by where projects sit on this timeline</li>
</ul>
</section>
<section id="competition" class="slide level2">
<h2>Competition</h2>
<ul>
<li>Patent protection usually lasts around 20 years (starts before drug is officially approved)</li>
<li>Companies can apply for extended patent protection for 5 years (max of 14 years in the market)</li>
<li>Additional 6 months if testing products in children</li>
<li>On average, 12.5 years of post-market exclusivity for widely used drugs and 14.5 years for highly innovative drugs (first-in-class)</li>
</ul>
</section>
<section class="slide level2">

<p>Limited competition even for brand name drugs with some substitutes. Why?</p>
<ul>
<li>Fragmentation</li>
<li>Information problems</li>
<li>Physician agency</li>
</ul>
</section>
<section class="slide level2">

<p>Firms can also deter generic entry, via:</p>
<ul>
<li>Additional patents on coating, method of administration, etc.
<ul>
<li>Example: Nexium is derivative of Prilosec (omeprazole), sold for 600% markup over generic omeprazole</li>
</ul></li>
<li>Significant settlements to generic drug companies</li>
<li>Delays in approval for generic drugs (FDA delays of 3-4 years, now closer to 1-2 years)</li>
</ul>
</section>
<section class="slide level2">

<p>Barriers to substituting brand name drugs with generic drugs even after generic entry:</p>
<ul>
<li>Drug product selection laws in 30 states that allow but do not require pharmacists to substitute generics</li>
<li>26 states that require patient consent when replacing brand name with generic drugs</li>
<li>All states allow “dispense-as-written”, which restricts pharmacists’ ability to substitute brand name drugs</li>
</ul>
</section>
<section id="drug-pricing-supply-chain" class="slide level2">
<h2>Drug Pricing Supply Chain</h2>
<ul>
<li>Already discussed…
<ul>
<li>Manufacturers set list prices and negotiate rebates with PBMs</li>
<li>Insurers reimburse pharmacies; patients face cost sharing at the pharmacy</li>
<li>PBM payment structures can weaken incentives to push aggressively for lower net prices</li>
</ul></li>
</ul>
</section>
<section class="slide level2">

<p>Other barriers to competition among generics and brand name:</p>
<ul>
<li>PBMs often paid based on insurer spending on specific drugs, therefore little incentive to intensely negotiate prices</li>
<li>From US House Committee on Oversight and Government reform:</li>
</ul>
<blockquote>
<p>“The investigation revealed, for example, that Turing received ‘no pushback from payors’ when it increased ‘Chenodal price 5x… [Thiola] price 21x… [and Daraprim] price 43x.’</p>
</blockquote>
</section>
<section id="justification-for-high-prices" class="slide level2">
<h2>Justification for high prices</h2>
<p>Industry argument that significant R&amp;D costs necessitate higher prices</p>
<div class="fragment">
<p>But…</p>
<ul>
<li>Half of the “most transformative drugs” developed (or started) in academic centers</li>
<li>Many drugs also started in small companies later acquired by larger manufacturer</li>
<li>“Innovation” means more than just another drug</li>
<li>Current price growth simply not sustainable</li>
</ul>
</div>
</section></section>
<section>
<section id="policy-responses-and-global-equity" class="title-slide slide level1 center">
<h1>Policy Responses and Global Equity</h1>

</section>
<section id="price-regulation-and-innovation" class="slide level2">
<h2>Price regulation and innovation</h2>
<ul>
<li>Price regulation (reference pricing, direct price caps, etc.)</li>
<li>In general, lower prices discourages innovation by shifting MEI inward</li>
<li>How much? Some estimates of price elasticity of R&amp;D at 0.6
<ul>
<li>10% price cut reduces R&amp;D by 6%</li>
</ul></li>
<li>But what innovations are “lost”? Hard to say</li>
</ul>
</section>
<section id="how-to-influence-innovation" class="slide level2">
<h2>How to influence innovation?</h2>
<ul>
<li>If firms are maximizing profits, then the only way to influence innovation is to change the MEI or the cost of capital</li>
<li>Shift MEI outward via:
<ul>
<li>Changing marketing regulations (DTC advertising)</li>
<li>Increasing demand for a drug (market exclusivity, coverage under public insurance)</li>
</ul></li>
<li>Shift cost of capital down via:
<ul>
<li>Easier access to funding (tax credits, grants, etc.)</li>
</ul></li>
</ul>
</section>
<section id="how-to-influence-innovation-1" class="slide level2">
<h2>How to influence innovation?</h2>
<ul>
<li>Which approach is “best”?</li>
</ul>
<div class="fragment">
<ul>
<li>Politically, these are NOT identical policies
<ul>
<li>Pull incentives require no up-front costs</li>
<li>Pull incentives tend to place R&amp;D burden onto pharma customers</li>
<li>Push incentives require up-front government investment</li>
<li>Push incentives place burden on taxpayers</li>
</ul></li>
</ul>
</div>
</section>
<section id="what-can-we-do" class="slide level2">
<h2>What can we do?</h2>
<p>Federal Policies:</p>
<ul>
<li>Limit secondary patents for minor changes</li>
<li>Combat anticompetitive practices like pay-for-delay</li>
<li>Allow negotiation of prices and formulary exclusions by Medicare</li>
<li>Faster time to market for generics</li>
</ul>
<p>State Policies:</p>
<ul>
<li>Drug product selection laws</li>
<li>Allow negotiation of prices and formulary exclusions by Medicaid</li>
</ul>
</section>
<section id="advanced-market-commitments-amcs" class="slide level2">
<h2>Advanced Market Commitments (AMCs)</h2>
<ul>
<li>Governments or donors commit <em>in advance</em> to buy a specified quantity of a vaccine or drug at a pre-set price</li>
<li>Goal: create a credible, profitable market for products that primarily benefit low-income countries</li>
<li>Example: AMC for pneumococcal vaccines in low-income countries</li>
<li>AMCs act like:
<ul>
<li>A pull incentive (payment conditional on success)</li>
<li>Targeted at areas where standard patent-based returns would be too low</li>
</ul></li>
</ul>
</section>
<section id="patent-buyouts-and-delinking" class="slide level2">
<h2>Patent Buyouts and Delinking</h2>
<ul>
<li>Patent buyouts:
<ul>
<li>Government buys the patent at an auction-based price plus a markup</li>
<li>Drug is then placed in the public domain (generic competition; low prices)</li>
</ul></li>
<li>Broader “delinkage” proposals:
<ul>
<li>Replace or reduce reliance on monopoly pricing</li>
<li>Reward firms through prizes or lump-sum payments tied to clinical and social value</li>
</ul></li>
<li>These ideas aim to preserve dynamic incentives for R&amp;D while reducing static monopoly distortions in prices</li>
</ul>
</section>
<section id="paper-discussion-2" class="slide level2">
<h2>Paper Discussion 2</h2>
<p><a href="https://www-nber-org.proxy.library.emory.edu/papers/w31272">PHARMACEUTICAL PRICING AND R&amp;D AS A GLOBAL PUBLIC GOOD</a></p>
</section>
<section id="who-pays-for-pharma-rd" class="slide level2">
<h2>Who Pays for Pharma R&amp;D?</h2>
<div>

</div>
<div class="quarto-layout-panel" data-layout="[[-1], [1], [-1]]">
<div class="quarto-layout-row">
<div class="quarto-figure-spacer quarto-layout-cell" style="flex-basis: 100.0%;justify-content: flex-start;">
<p>&nbsp;</p>
</div>
</div>
<div class="quarto-layout-row">
<div class="quarto-layout-cell" style="flex-basis: 100.0%;justify-content: center;">
<div class="quarto-figure quarto-figure-center">
<figure>
<p><img data-src="../figures/global_pharma_sales_regions.png" class="quarto-figure quarto-figure-center"></p>
</figure>
</div>
</div>
</div>
</div>
<ul>
<li>The U.S. accounts for a disproportionate share of global pharmaceutical sales (stylized)</li>
<li>Other high-income regions also contribute, but to a lesser extent</li>
<li>Sets up the question of whether the U.S. is over-contributing to global R&amp;D incentives</li>
</ul>
</section>
<section id="us-subsidizing-row" class="slide level2">
<h2>US Subsidizing ROW</h2>
<ul>
<li>US clearly pays higher prices than other countries</li>
<li>Strong evidence that US contribution to profit for future innovation is higher than it should be</li>
<li>That said, the ROW contribution is meaningful (all other countries do not force prices to marginal costs)</li>
<li>Authors urge a more international view of spending, suggesting better policy is to advocate for higher prices elsewhere rather than directly for lower prices in the US</li>
</ul>
</section>
<section id="pulling-it-together-designing-rd-incentives" class="slide level2">
<h2>Pulling It Together: Designing R&amp;D Incentives</h2>
<ul>
<li>Standard patent system: strong dynamic incentives but high prices and uneven R&amp;D portfolio</li>
<li>Distortions:
<ul>
<li>Treatments vs preventives</li>
<li>Short- vs long-horizon projects</li>
<li>Diseases of rich vs poor countries</li>
</ul></li>
<li>Policy menu:
<ul>
<li>Adjust prices and coverage (Medicare/Medicaid negotiations, global pricing)</li>
<li>Add targeted push and pull incentives (NIH funding, AMCs, prizes, buyouts)</li>
</ul></li>
<li>Open question: what mix best balances current access, future innovation, and global equity?</li>
</ul>
<div class="quarto-auto-generated-content">
<div class="footer footer-default">

</div>
</div>
</section></section>
    </div>
  </div>

  <script>window.backupDefine = window.define; window.define = undefined;</script>
  <script src="pharma-04_files/libs/revealjs/dist/reveal.js"></script>
  <!-- reveal.js plugins -->
  <script src="pharma-04_files/libs/revealjs/plugin/quarto-line-highlight/line-highlight.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/pdf-export/pdfexport.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/reveal-menu/menu.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/reveal-menu/quarto-menu.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/reveal-chalkboard/plugin.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/quarto-support/support.js"></script>
  

  <script src="pharma-04_files/libs/revealjs/plugin/notes/notes.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/search/search.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/zoom/zoom.js"></script>
  <script src="pharma-04_files/libs/revealjs/plugin/math/math.js"></script>
  <script>window.define = window.backupDefine; window.backupDefine = undefined;</script>

  <script>

      // Full list of configuration options available at:
      // https://revealjs.com/config/
      Reveal.initialize({
'controlsAuto': true,
'previewLinksAuto': true,
'pdfSeparateFragments': false,
'autoAnimateEasing': "ease",
'autoAnimateDuration': 1,
'autoAnimateUnmatched': true,
'menu': {"side":"left","useTextContentForMissingTitles":true,"markers":false,"loadIcons":false,"custom":[{"title":"Tools","icon":"<i class=\"fas fa-gear\"></i>","content":"<ul class=\"slide-menu-items\">\n<li class=\"slide-tool-item active\" data-item=\"0\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.fullscreen(event)\"><kbd>f</kbd> Fullscreen</a></li>\n<li class=\"slide-tool-item\" data-item=\"1\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.speakerMode(event)\"><kbd>s</kbd> Speaker View</a></li>\n<li class=\"slide-tool-item\" data-item=\"2\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.overview(event)\"><kbd>o</kbd> Slide Overview</a></li>\n<li class=\"slide-tool-item\" data-item=\"3\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.togglePdfExport(event)\"><kbd>e</kbd> PDF Export Mode</a></li>\n<li class=\"slide-tool-item\" data-item=\"4\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleChalkboard(event)\"><kbd>b</kbd> Toggle Chalkboard</a></li>\n<li class=\"slide-tool-item\" data-item=\"5\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.toggleNotesCanvas(event)\"><kbd>c</kbd> Toggle Notes Canvas</a></li>\n<li class=\"slide-tool-item\" data-item=\"6\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.downloadDrawings(event)\"><kbd>d</kbd> Download Drawings</a></li>\n<li class=\"slide-tool-item\" data-item=\"7\"><a href=\"#\" onclick=\"RevealMenuToolHandlers.keyboardHelp(event)\"><kbd>?</kbd> Keyboard Help</a></li>\n</ul>"}],"openButton":true},
'chalkboard': {"buttons":true,"boardmarkerWidth":5},
'smaller': false,
 
        // Display controls in the bottom right corner
        controls: false,

        // Help the user learn the controls by providing hints, for example by
        // bouncing the down arrow when they first encounter a vertical slide
        controlsTutorial: false,

        // Determines where controls appear, "edges" or "bottom-right"
        controlsLayout: 'edges',

        // Visibility rule for backwards navigation arrows; "faded", "hidden"
        // or "visible"
        controlsBackArrows: 'faded',

        // Display a presentation progress bar
        progress: true,

        // Display the page number of the current slide
        slideNumber: 'c/t',

        // 'all', 'print', or 'speaker'
        showSlideNumber: 'all',

        // Add the current slide number to the URL hash so that reloading the
        // page/copying the URL will return you to the same slide
        hash: true,

        // Start with 1 for the hash rather than 0
        hashOneBasedIndex: false,

        // Flags if we should monitor the hash and change slides accordingly
        respondToHashChanges: true,

        // Push each slide change to the browser history
        history: true,

        // Enable keyboard shortcuts for navigation
        keyboard: true,

        // Enable the slide overview mode
        overview: true,

        // Disables the default reveal.js slide layout (scaling and centering)
        // so that you can use custom CSS layout
        disableLayout: false,

        // Vertical centering of slides
        center: false,

        // Enables touch navigation on devices with touch input
        touch: true,

        // Loop the presentation
        loop: false,

        // Change the presentation direction to be RTL
        rtl: false,

        // see https://revealjs.com/vertical-slides/#navigation-mode
        navigationMode: 'linear',

        // Randomizes the order of slides each time the presentation loads
        shuffle: false,

        // Turns fragments on and off globally
        fragments: true,

        // Flags whether to include the current fragment in the URL,
        // so that reloading brings you to the same fragment position
        fragmentInURL: false,

        // Flags if the presentation is running in an embedded mode,
        // i.e. contained within a limited portion of the screen
        embedded: false,

        // Flags if we should show a help overlay when the questionmark
        // key is pressed
        help: true,

        // Flags if it should be possible to pause the presentation (blackout)
        pause: true,

        // Flags if speaker notes should be visible to all viewers
        showNotes: false,

        // Global override for autoplaying embedded media (null/true/false)
        autoPlayMedia: null,

        // Global override for preloading lazy-loaded iframes (null/true/false)
        preloadIframes: null,

        // Number of milliseconds between automatically proceeding to the
        // next slide, disabled when set to 0, this value can be overwritten
        // by using a data-autoslide attribute on your slides
        autoSlide: 0,

        // Stop auto-sliding after user input
        autoSlideStoppable: true,

        // Use this method for navigation when auto-sliding
        autoSlideMethod: null,

        // Specify the average time in seconds that you think you will spend
        // presenting each slide. This is used to show a pacing timer in the
        // speaker view
        defaultTiming: null,

        // Enable slide navigation via mouse wheel
        mouseWheel: false,

        // The display mode that will be used to show slides
        display: 'block',

        // Hide cursor if inactive
        hideInactiveCursor: true,

        // Time before the cursor is hidden (in ms)
        hideCursorTime: 5000,

        // Opens links in an iframe preview overlay
        previewLinks: false,

        // Transition style (none/fade/slide/convex/concave/zoom)
        transition: 'none',

        // Transition speed (default/fast/slow)
        transitionSpeed: 'default',

        // Transition style for full page slide backgrounds
        // (none/fade/slide/convex/concave/zoom)
        backgroundTransition: 'none',

        // Number of slides away from the current that are visible
        viewDistance: 3,

        // Number of slides away from the current that are visible on mobile
        // devices. It is advisable to set this to a lower number than
        // viewDistance in order to save resources.
        mobileViewDistance: 2,

        // The "normal" size of the presentation, aspect ratio will be preserved
        // when the presentation is scaled to fit different resolutions. Can be
        // specified using percentage units.
        width: 1600,

        height: 900,

        // Factor of the display size that should remain empty around the content
        margin: 0.1,

        math: {
          mathjax: 'https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.0/MathJax.js',
          config: 'TeX-AMS_HTML-full',
          tex2jax: {
            inlineMath: [['\\(','\\)']],
            displayMath: [['\\[','\\]']],
            balanceBraces: true,
            processEscapes: false,
            processRefs: true,
            processEnvironments: true,
            preview: 'TeX',
            skipTags: ['script','noscript','style','textarea','pre','code'],
            ignoreClass: 'tex2jax_ignore',
            processClass: 'tex2jax_process'
          },
        },

        // reveal.js plugins
        plugins: [QuartoLineHighlight, PdfExport, RevealMenu, RevealChalkboard, QuartoSupport,

          RevealMath,
          RevealNotes,
          RevealSearch,
          RevealZoom
        ]
      });
    </script>
    

    <script>

      // htmlwidgets need to know to resize themselves when slides are shown/hidden.

      // Fire the "slideenter" event (handled by htmlwidgets.js) when the current

      // slide changes (different for each slide format).

      (function () {

        // dispatch for htmlwidgets

        function fireSlideEnter() {

          const event = window.document.createEvent("Event");

          event.initEvent("slideenter", true, true);

          window.document.dispatchEvent(event);

        }

    

        function fireSlideChanged(previousSlide, currentSlide) {

          fireSlideEnter();

    

          // dispatch for shiny

          if (window.jQuery) {

            if (previousSlide) {

              window.jQuery(previousSlide).trigger("hidden");

            }

            if (currentSlide) {

              window.jQuery(currentSlide).trigger("shown");

            }

          }

        }

    

        // hookup for slidy

        if (window.w3c_slidy) {

          window.w3c_slidy.add_observer(function (slide_num) {

            // slide_num starts at position 1

            fireSlideChanged(null, w3c_slidy.slides[slide_num - 1]);

          });

        }

    

      })();

    </script>

    

    <script id="quarto-html-after-body" type="application/javascript">
    window.document.addEventListener("DOMContentLoaded", function (event) {
      const toggleBodyColorMode = (bsSheetEl) => {
        const mode = bsSheetEl.getAttribute("data-mode");
        const bodyEl = window.document.querySelector("body");
        if (mode === "dark") {
          bodyEl.classList.add("quarto-dark");
          bodyEl.classList.remove("quarto-light");
        } else {
          bodyEl.classList.add("quarto-light");
          bodyEl.classList.remove("quarto-dark");
        }
      }
      const toggleBodyColorPrimary = () => {
        const bsSheetEl = window.document.querySelector("link#quarto-bootstrap");
        if (bsSheetEl) {
          toggleBodyColorMode(bsSheetEl);
        }
      }
      toggleBodyColorPrimary();  
      const tabsets =  window.document.querySelectorAll(".panel-tabset-tabby")
      tabsets.forEach(function(tabset) {
        const tabby = new Tabby('#' + tabset.id);
      });
      const isCodeAnnotation = (el) => {
        for (const clz of el.classList) {
          if (clz.startsWith('code-annotation-')) {                     
            return true;
          }
        }
        return false;
      }
      const onCopySuccess = function(e) {
        // button target
        const button = e.trigger;
        // don't keep focus
        button.blur();
        // flash "checked"
        button.classList.add('code-copy-button-checked');
        var currentTitle = button.getAttribute("title");
        button.setAttribute("title", "Copied!");
        let tooltip;
        if (window.bootstrap) {
          button.setAttribute("data-bs-toggle", "tooltip");
          button.setAttribute("data-bs-placement", "left");
          button.setAttribute("data-bs-title", "Copied!");
          tooltip = new bootstrap.Tooltip(button, 
            { trigger: "manual", 
              customClass: "code-copy-button-tooltip",
              offset: [0, -8]});
          tooltip.show();    
        }
        setTimeout(function() {
          if (tooltip) {
            tooltip.hide();
            button.removeAttribute("data-bs-title");
            button.removeAttribute("data-bs-toggle");
            button.removeAttribute("data-bs-placement");
          }
          button.setAttribute("title", currentTitle);
          button.classList.remove('code-copy-button-checked');
        }, 1000);
        // clear code selection
        e.clearSelection();
      }
      const getTextToCopy = function(trigger) {
          const codeEl = trigger.previousElementSibling.cloneNode(true);
          for (const childEl of codeEl.children) {
            if (isCodeAnnotation(childEl)) {
              childEl.remove();
            }
          }
          return codeEl.innerText;
      }
      const clipboard = new window.ClipboardJS('.code-copy-button:not([data-in-quarto-modal])', {
        text: getTextToCopy
      });
      clipboard.on('success', onCopySuccess);
      if (window.document.getElementById('quarto-embedded-source-code-modal')) {
        // For code content inside modals, clipBoardJS needs to be initialized with a container option
        // TODO: Check when it could be a function (https://github.com/zenorocha/clipboard.js/issues/860)
        const clipboardModal = new window.ClipboardJS('.code-copy-button[data-in-quarto-modal]', {
          text: getTextToCopy,
          container: window.document.getElementById('quarto-embedded-source-code-modal')
        });
        clipboardModal.on('success', onCopySuccess);
      }
        var localhostRegex = new RegExp(/^(?:http|https):\/\/localhost\:?[0-9]*\//);
        var mailtoRegex = new RegExp(/^mailto:/);
          var filterRegex = new RegExp('/' + window.location.host + '/');
        var isInternal = (href) => {
            return filterRegex.test(href) || localhostRegex.test(href) || mailtoRegex.test(href);
        }
        // Inspect non-navigation links and adorn them if external
     	var links = window.document.querySelectorAll('a[href]:not(.nav-link):not(.navbar-brand):not(.toc-action):not(.sidebar-link):not(.sidebar-item-toggle):not(.pagination-link):not(.no-external):not([aria-hidden]):not(.dropdown-item):not(.quarto-navigation-tool):not(.about-link)');
        for (var i=0; i<links.length; i++) {
          const link = links[i];
          if (!isInternal(link.href)) {
            // undo the damage that might have been done by quarto-nav.js in the case of
            // links that we want to consider external
            if (link.dataset.originalHref !== undefined) {
              link.href = link.dataset.originalHref;
            }
          }
        }
      function tippyHover(el, contentFn, onTriggerFn, onUntriggerFn) {
        const config = {
          allowHTML: true,
          maxWidth: 500,
          delay: 100,
          arrow: false,
          appendTo: function(el) {
              return el.closest('section.slide') || el.parentElement;
          },
          interactive: true,
          interactiveBorder: 10,
          theme: 'light-border',
          placement: 'bottom-start',
        };
        if (contentFn) {
          config.content = contentFn;
        }
        if (onTriggerFn) {
          config.onTrigger = onTriggerFn;
        }
        if (onUntriggerFn) {
          config.onUntrigger = onUntriggerFn;
        }
          config['offset'] = [0,0];
          config['maxWidth'] = 700;
        window.tippy(el, config); 
      }
      const noterefs = window.document.querySelectorAll('a[role="doc-noteref"]');
      for (var i=0; i<noterefs.length; i++) {
        const ref = noterefs[i];
        tippyHover(ref, function() {
          // use id or data attribute instead here
          let href = ref.getAttribute('data-footnote-href') || ref.getAttribute('href');
          try { href = new URL(href).hash; } catch {}
          const id = href.replace(/^#\/?/, "");
          const note = window.document.getElementById(id);
          if (note) {
            return note.innerHTML;
          } else {
            return "";
          }
        });
      }
      const findCites = (el) => {
        const parentEl = el.parentElement;
        if (parentEl) {
          const cites = parentEl.dataset.cites;
          if (cites) {
            return {
              el,
              cites: cites.split(' ')
            };
          } else {
            return findCites(el.parentElement)
          }
        } else {
          return undefined;
        }
      };
      var bibliorefs = window.document.querySelectorAll('a[role="doc-biblioref"]');
      for (var i=0; i<bibliorefs.length; i++) {
        const ref = bibliorefs[i];
        const citeInfo = findCites(ref);
        if (citeInfo) {
          tippyHover(citeInfo.el, function() {
            var popup = window.document.createElement('div');
            citeInfo.cites.forEach(function(cite) {
              var citeDiv = window.document.createElement('div');
              citeDiv.classList.add('hanging-indent');
              citeDiv.classList.add('csl-entry');
              var biblioDiv = window.document.getElementById('ref-' + cite);
              if (biblioDiv) {
                citeDiv.innerHTML = biblioDiv.innerHTML;
              }
              popup.appendChild(citeDiv);
            });
            return popup.innerHTML;
          });
        }
      }
    });
    </script>
    

</body></html>